XM does not provide services to residents of the United States of America.
Q
Q

Qualcomm

Trade Ideas

Traders Sentiment

Technical Summary

Hourly

News

US chipmakers recover from tech rout after TSMC beats Q2 profit estimates

BUZZ-US chipmakers recover from tech rout after TSMC beats Q2 profit estimates ** Shares of U.S. chipmakers gain premarket after Taiwan Semiconductor Manufacturing TSM.N beat profit estimates for Q2 ** The contract chipmaker expects higher revenue in its current quarter as AI drives demand, sending its U.S.-listed shares 3.6% higher ** TSMC's upbeat forecast helps U.S.
B
I
M
M
N
Q
A
L
T
U

U.S. Elevance Health, J&J, Primerica

U.S. RESEARCH ROUNDUP-Elevance Health, J&J, Primerica July 18 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Elevance Health, J&J and Primerica, on Thursday. HIGHLIGHTS * Elevance Health Inc ELV.N : Leerink Partners cuts target price to $620 from $630 * J&J JNJ.N : TD Cowen cuts target price to $185 from $195 * Primerica Inc PRI.N : Jefferies raises target price to $249 from $239 * Travelers Companies Inc TRV.N : HS
A
A
O
P
Q
A
A
C

US chip stocks hit by China trade worries; Intel bucks trend

BUZZ-US chip stocks hit by China trade worries; Intel bucks trend Updates ** Chipmakers' shares tumble amid concerns about U.S.-China trade tensions and rout in the tech sector in the United States ** The U.S. has told its allies it is considering using the most severe trade restrictions available if companies continue giving China access to advanced semiconductor technology, Bloomberg News reported ** Nasdaq Composite index .IXIC falls 1.7% .N ** AI chipmaker Nvidia's NVDA.O shares fall 4.1%, m
B
I
M
M
N
Q
A
K
L
U

Nasdaq hits two-week low in megacap tech, chip stocks rout

US STOCKS-Nasdaq hits two-week low in megacap tech, chip stocks rout For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window. Chip stocks tumble on China trade worries, tech sell-off J&J up after beating estimates on strong drug sales Lilly down as rival Roche reports early data for obesity pill Spirit Airlines slips after lowered Q2 forecast Indexes: Dow up 0.07%, S&P down 0.96%, Nasdaq down 1.83% Updated at 9:45 a.m.
A
B
I
M
M
M
N
N
Q
T
A
U
U

Chip stocks shed over $500 billion in value on China trade fears

UPDATE 3-Chip stocks shed over $500 billion in value on China trade fears Adds price moves, context on chip industry By Arsheeya Bajwa July 17 (Reuters) - Wall Street's semiconductor index lost more than $500 billion in stock market value on Wednesday in its worst session since 2020 after a report said the United States was mulling tighter curbs on exports of advanced semiconductor technology to China.
B
I
M
N
Q
A
A
K
T
U

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.